Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention

Published:2024-07-30 Issue:15 Volume:67 Page:13392-13408
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Galbiati Andrea¹^ORCID,Bocci Matilde¹^ORCID,Gervasoni Silvia²^ORCID,Prodi Eleonora¹,Malloci Giuliano²^ORCID,Neri Dario³⁴,Cazzamalli Samuele¹^ORCID

Affiliation:

1. R&D Department, Philochem AG, CH-8112 Otelfingen, Switzerland

2. Department of Physics, University of Cagliari, Cagliari I-09042, Monserrato, Italy

3. Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology, CH-8093 Zurich, Switzerland

4. Philogen S.p.A., I-53100 Siena, Italy

Funder

Ministero dell'Universit? e della Ricerca

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c01295

Reference64 articles.

1. The Anticancer Drugs. By WILLIAM B. PRATT and RAYMOND W. RUDDON. Oxford University Press, 200 Madison Ave., New York, NY 10016, 1979. 323pp. 15 × 23cm. Price $18.95 hard cover or $12.95 soft cover

2. Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients

3. Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

4. Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

5. Clinical radioimmunotherapy—the role of radiobiology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives;European Journal of Medicinal Chemistry;2024-11

2. Preclinical Evaluation of¹⁷⁷Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors;Journal of Nuclear Medicine;2024-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3